Interview with Sue MacLeman, CEO on Boardroom Radio | 8 February 2010
Nature Biotechnology | January 2010
The intellectual property landscape for gene suppression technologies in plants
NSi Collaboration with Benitec to Develop an RNAi Therapeutic for Lung Cancer | November 2009
Nature Journal | January 22, 2009
The promises and pitfalls of RNA-interference-based therapeutics
Intersuisse Report London Forum | October, 2007
Intersuisse Investment Research | August 1, 2007
DNA-directed RNAi and the crown jewels
Australian Life Scientist, April 1, 2007
Benitec Featured in the Australian | November 11, 2006
Benitec hopes big Merck deal will silence critics | The Age, November 6, 2006
In the Range | The Daily Telegraph, November 1, 2006
Benitec Featured on ABC TV's Catalyst | April 20, 2006
Link
Health Journal Television Interview
WMV
Video Feed
Chemistry & Industry | February 21, 2005
Running
Interference (pdf 3.5MB)
BioIT World | February 18, 2005
RNAi Therapeutics (pdf 185k)
VentureWire Alert | October 7, 2004
Venture Market Summary: RNAi Overview (pdf 41k)
Daily
Telegraph | September 23, 2004
In Human Eyes, Hope of Taming Bad Genes (pdf 207k)
New
York Times | September 14, 2004
Method to Turn Off Bad Genes Is Set for Tests on Human Eyes (pdf 156k)
Wired
| August 13, 2004
Building
Blocks for a Tiny World
Ribonucleic acid, or RNA, is no longer just a slave to DNA's commands.
It may be the strongest building material yet for making nanostructures.
Drug
Discovery & Development | August, 2004
The Sound of RNAi Silencing (pdf 919k)
